The DJS Law Group reminds investors of a class action lawsuit against Dow Inc. (“Dow ” or “the Company”) (NYSE: DOW ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of SMLR during the […]
The DJS Law Group reminds investors of a class action lawsuit against LifeMD, Inc. (“LifeMD ” or “the Company”) (NASDAQ: LFMD ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of LFMD during the
TheSchall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit againstLifeMD, Inc. (“LifeMD” or “the Company”) (NASDAQ: LFMD) forviolations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg Investors who purchased the Company's securities
Envision Energy, a global leader in green technology, announced the full rollout of its Gen 8 Scalable Platform at its Tech Day in Beijing. Following the debut of the 8 MWh solution at Intersolar earlier this year, the company is now introducing the complete portfolio of modular configurations, designed to meet a wide spectrum of
CITRYLL PRESENTS POSITIVE DATA FROM PHASE I STUDY OF CIT-013 IN RHEUMATOID ARTHRITIS AT ACR CONVERGENCE 2025 Phase I trial data in rheumatoid arthritis patients demonstrates favorable safety, encouraging clinical activity, and robust biomarker responses Data provides strong validation for the advancement of CIT-013 into Phase IIa studies Oss, Netherlands – 27 October 2025 –
Citryll Presents Positive Data from Phase I Study of CIT-013 in Rheumatoid Arthritis at ACR Convergence 2025 GlobeNewswire October 27, 2025 CITRYLL PRESENTS POSITIVE DATA FROM PHASE I STUDY OF CIT-013 IN RHEUMATOID ARTHRITIS AT ACR CONVERGENCE 2025 Phase I trial data in rheumatoid arthritis patients demonstrates favorable safety, encouraging clinical activity, and robust biomarker
Health-tech companyMINISH Technology Inc. announced on the 27th that 22 dentists completed its 15th MINISH Course, the first session held for local practitioners in the United States. https://mma.prnewswire.com/media/2805604/MINISH_Technology.jpg The three-day course was held from October 24 to 26 at the VITA North America training center in Orange County, California, as an officially recognized Continuing Education
Advances made in preclinical pipeline addressing neurodegenerative diseases Evotec receives US$ 25 m payment to support continued progression of joint programs HAMBURG, DE / ACCESS Newswire / October 27, 2025 / Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE0005664809, WKN 566480; NASDAQ:EVO) today announced that the Company has received a payment of
STOCKHOLM, SE / ACCESS Newswire / October 27, 2025 / Hacksaw (STO:HACK) – The Nomination Committee of Hacksaw AB (publ) has been appointed for the Annual General Meeting 2026. In accordance with the decision by the general meeting on 13 May 2025, the Nomination Committee shall consist of representatives of the three largest shareholders as
Industry Milestone! RWA.LTD Becomes the First Application of x402 Protocol on BSC Chain In the wave of Real World Asset (RWA) tokenization, RWA.LTD once again sets a new industry record! As the world's first non-financial RWA trading platform, we are proud to announce: RWA.LTD has become the first application of the x402 Protocol on the